H25.23 Age-related cataract, morgagnian type, bilateral

Name of the Condition

• Age-related Cataract, Morgagnian Type, Bilateral
• Technical term: H25.23

Summary

Age-related cataract, morgagnian type, bilateral, is a specific form of cataract characterized by the liquefaction of the lens nucleus and sinking of dense, opaque material within the lens capsule in both eyes. This condition typically occurs in advanced stages of cataract development and may lead to significant visual impairment. The liquefied cortex and displaced nucleus can cause rapid changes in vision and increase the risk of complications during surgical intervention.

Causes

The primary cause is advanced age-related degeneration of the lens, leading to the breakdown of lens proteins and fibers. Over time, the nucleus becomes hypermature, and the surrounding cortex liquefies, allowing the dense nuclear material to sink inferiorly within the lens capsule. This process is part of the natural progression of untreated or long-standing cataracts.

Risk Factors

• Advanced age: Most common in older adults with long-standing cataracts.
• Prolonged untreated cataracts: Increases the likelihood of nuclear liquefaction.
• Ocular trauma or inflammation: May accelerate lens degeneration.
• Systemic conditions: Diabetes or other metabolic disorders can contribute to lens changes.

Symptoms

• Sudden or rapid decline in vision in both eyes.
• Increased glare sensitivity, especially in bright light.
• Blurred or distorted vision.
• Difficulty with night vision.
• Changes in color perception.

Diagnosis

Diagnosis involves a comprehensive eye examination, including visual acuity testing, slit-lamp biomicroscopy, and dilated fundus examination. The presence of a hypermature cataract with a sunken nucleus and liquefied cortex is characteristic. Additional tests, such as ocular coherence tomography (OCT) or ultrasound biomicroscopy, may be used to assess lens integrity and plan surgical intervention.

Treatment Options

• Surgical intervention: Phacoemulsification with intraocular lens (IOL) implantation is the standard treatment. The liquefied cortex and displaced nucleus require careful extraction to minimize complications.
• Preoperative planning: Special considerations for bilateral cases may include staging surgeries to manage visual recovery and reduce postoperative risks.
• Postoperative care: Topical medications and follow-up to monitor healing and visual outcomes.

Prognosis and Follow-Up

Prognosis is generally good with timely surgical intervention, though bilateral cases may require careful management of visual rehabilitation. Follow-up appointments are essential to monitor for complications, such as posterior capsule opacification or infection, and to adjust visual aids as needed.

Complications

• Surgical challenges: Increased risk of capsular rupture or lens material dislocation during extraction.
• Postoperative issues: Higher likelihood of posterior capsule opacification or inflammation.
• Visual disturbances: Persistent glare or reduced contrast sensitivity in some cases.

Lifestyle & Prevention

• Regular eye exams: Early detection of cataract progression can help manage symptoms.
• UV protection: Wearing sunglasses may slow lens degeneration.
• Healthy diet: Nutrients like antioxidants (e.g., vitamins C and E) may support lens health.
• Manage systemic conditions: Controlling diabetes or other metabolic disorders can reduce cataract progression.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision loss, increased glare, or pain in either eye, as these may indicate complications requiring urgent intervention.

Tips for Medical Coders

Document the bilateral nature of the condition clearly in the medical record. Ensure the diagnosis aligns with clinical findings of morgagnian cataract in both eyes, including details of lens liquefaction and nuclear displacement. Verify that the code H25.23 is used only when both eyes are affected, as opposed to unilateral or unspecified cases.